COVID-X is an exclusive acceleration program funded by the European Commission as part of the response plan to defeat COVID-19 with data-driven technology.
The program will grant EU companies [Single Players] with 100K€ in equity-free funding to validate their data solutions in one of the clinical partners from Italy, Spain or Sweden. If the company brings in a Healthcare Provider that can validate the solution [Team Players], the financial support will go up to 150K€ .
The focus will be on clinical challenges related to diagnosis, prognosis or follow-up of COVID-19 patients, or on a new open challenge.
The Open Call#2, running now, will select 15+ top-ranked solutions & the deadline for applications is on 22.07.2021 at 17:00 CEST (Brussels Time).
This is the deadline for the 1st Application Stage validating that the applicants meet the required selection criteria [TRL7+ , CE marking (or in process of) and a solid implementation plan]. Moreover, all selected applications are invited to submit their full proposal in the 2nd Application Stage from early August until the end September.
The selected solutions will join their 10-months acceleration program to boost a quick market uptake. The plan of action will include technical support, ethical validation, and business coaching. In addition, participants deploy the COVID-X Sandbox, a one-stop platform to exploit COVID-19 data sources, incorporating general information on data silos, as well as the integration, visualization, and exploratory analysis for easy understanding.
More info: www.covid-x.eu
Applications on F6S platform : www.f6s.com/covid-x/
Contact person at Enterprise Europe Brussels: Emilie Fonck
